June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Real-Time Assessment of Corneal Endothelial Cell Damage Following DMEK Graft Preparation and Insertion
Author Affiliations & Notes
  • Gary S L Peh
    Singapore Eye Research Institute, Singapore, Singapore
    Duke-NUS Graduate Medical School, Singapore, Singapore
  • Maninder S Bhogal
    Moorfields Eye Hospital, London, United Kingdom
    Singapore Eye Research Institute, Singapore, Singapore
  • Chan Nyein Lwin
    Singapore Eye Research Institute, Singapore, Singapore
  • Xin-Yi Seah
    Singapore Eye Research Institute, Singapore, Singapore
  • Khadijah Binte Adnan
    Singapore Eye Research Institute, Singapore, Singapore
  • Elavazhagan Murugan
    Singapore Eye Research Institute, Singapore, Singapore
  • Jodhbir Mehta
    Singapore National Eye Centre, Singapore, Singapore
    Singapore Eye Research Institute, Singapore, Singapore
  • Footnotes
    Commercial Relationships   Gary Peh, None; Maninder Bhogal, None; Chan Lwin, None; Xin-Yi Seah, None; Khadijah Adnan, None; Elavazhagan Murugan, None; Jodhbir Mehta, None
  • Footnotes
    Support  NMRC/TCR/008-SERI/2013
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 1478. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Gary S L Peh, Maninder S Bhogal, Chan Nyein Lwin, Xin-Yi Seah, Khadijah Binte Adnan, Elavazhagan Murugan, Jodhbir Mehta; Real-Time Assessment of Corneal Endothelial Cell Damage Following DMEK Graft Preparation and Insertion. Invest. Ophthalmol. Vis. Sci. 2017;58(8):1478.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : This study describes a method that enable accurate evaluation of graft viability with a single incubation of a fluorescent viability dye that can be tracked following in-situ graft preparation through to implantation and its subsequent assessment in-vivo.

Methods : Optimization of viability dye was performed on cultured corneal endothelial cells (CEnCs) expanded for at least 2 passages, isolated from donor corneas unsuitable for transplantation. Cells were incubated with varying concentrations of calcein AM (CAM), and fluorescence intensity was measured. Cellular toxicity of CAM to cultured CEnCs was also assessed by flow cytometry. For assessment of the cell viability of DMEK graft in-situ, transplant-grade corneas were procured and prepared as per for DMEK surgery. Imaging was performed at 3 time points: prior to graft preparation, following preparation and imaging of the unfolded graft within the anterior chamber of a porcine globe. All images were exported to ImageJ for processing and quantification, where viability based on CAM/eithidium homodimer/Hoechst labelling was assessed. Trypan blue/Alizarin red viability staining was also performed. All statistical analyses were performed using GraphPad Prism, and a p-value of <0.05 was deemed to be significant.

Results : Of the concentrations evaluated, 2.67 µM were found to be sufficient for imaging with the Spectralis HRA. At 2.67 µM, viability of labelled CEnCs was not significantly affected compared to unlabeled cells (2.72% vs 3.96%, p = 0.25), and morphometric analysis showed no significant differences between labelled and control corneas. Following implantation of pre-labelled graft, high quality images can be obtained when imaging through fresh or 24hr-old edematous porcine cornea. Areas of non-viability detected using in-situ imaging showed good agreement with the in-vivo global viability method. Estimates of cell density based on CAM fluorescence showed a strong positive correlation with Hoechst positive cells from the same graft region ex-vivo (R=0.74, p<0.0001)

Conclusions : We have developed and validated a method for sequential graft viability assessment that can be applied at every stage of transplantation. The methodology utilizes current clinical imaging device, where with minor adaptation enabled in vivo assessments of overall graft viability and cell density of the whole graft.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×